Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys to Help Northrop Grumman Build Bioagent Detectors for US Government

NEW YORK, Sept. 3 (GenomeWeb News) - Accelrys will help aerospace giant Northrop Grumman research and develop bioagent detectors for the US Department of Homeland Security, Accelrys said this week.

 

Terms of the agreement call for Accelrys to use its statistical modeling and analysis technology to help determine the "anticipated sensitivity and selectivity" of the detectors, which the DHS will use to monitor for the presence of certain undisclosed bacteria, viruses, and toxin-proteins.

 

It was not immediately known which software Accelrys will contribute to the collaboration.

 

Northrop Grumman was one of 14 companies and universities contracted by the Homeland Security Advance Research Projects Agency to research and develop "measures for defending against biological threats."

The aerospace company will receive a portion of a $48 million award among these 14 teams during an initial 18-month R&D phase. Accelrys did not disclose whether or how much it will be paid for its contribution. Northrop Grumman and Accelrys will be developing Bioagent Autonomous Networked Detectors, which will be used to continuously monitor for bioagents in outdoor urban areas, the companies said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.